SCHEMBL7989387

SCHEMBL7989387

NC(=O)c1c(NC(=O)c2ccc(OCCN3CCOCC3)cc2)ncn1Cc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
L3MBTL1 Q9Y468 1/20 0.49
LTA4H P09960 1/20 0.48
FLT3 P36888 4/20 0.48
AURKA O14965 2/20 0.48
KDR P35968 2/20 0.48
KDM4E B2RXH2 1/20 0.48
FLT1 P17948 1/20 0.48
HDAC1 Q13547 1/20 0.48
ABL1 P00519 1/20 0.47
TUBB4A P04350 1/20 0.47
TUBB P07437 1/20 0.47
LYN P07948 1/20 0.47
TUBA3C P0DPH7 1/20 0.47
BCR P11274 1/20 0.47
SRC P12931 1/20 0.47
TUBA1B P68363 1/20 0.47
TUBA4A P68366 1/20 0.47
TUBB4B P68371 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7987486 0.91 KDM4E (0.48) SMN1; SMN2AURKAKDRKDM4EHDAC1
SCHEMBL7974029 0.80 ADORA3 (0.50) ALDH1A1L3MBTL1KDM4EHDAC1
SCHEMBL7975241 0.80 GAA (0.50) SMN1; SMN2FLT3HDAC1GAA
SCHEMBL7988029 0.78 IDO1 (0.47) SMN1; SMN2FLT3HDAC1BCHEGAA
SCHEMBL7985255 0.77 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2L3MBTL1FLT3KDM4E
SCHEMBL7988231 0.77 NPC1 (0.47) HDAC1
SCHEMBL7985682 0.76 GAA (0.46) ALDH1A1SMN1; SMN2KDM4EFLT1HDAC1
SCHEMBL7984687 0.75 NR1H4 (0.52) ALDH1A1
SCHEMBL7974581 0.74 LMNA (0.51) ALDH1A1SMN1; SMN2FLT3HDAC1GAA
SCHEMBL7974265 0.74 MCHR1 (0.47) SMN1; SMN2L3MBTL1FLT3KDM4EHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed